http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1034879-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-65
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
filingDate 1965-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1966-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1034879-A
titleOfInvention Lower alkoxy pyridyl acetones
abstract The invention comprises (3-lower alkoxy-2-pyridyl)-acetones and their preparation by treating 3-lower alkoxy-2-methylpyridine with n-butyl lithium in the presence of an inert solvent such as absolute ether or dry hexane, under an inert atmosphere, adding acetonitrile and acidifying with an aqueous acid solution, treating the aqueous phase of the mixture with an alkali metal hydroxide and methylene chloride, separating the aqueous phase from said mixture and recovering the acetone product from the organic phase. The products of said process may be converted to (3-lower alkoxy-2-piperidyl) acetone by selective reduction of the pyridino ring with hydrogen over rhodium catalyst in acidic solution. The latter compounds are useful for preparing antimalarial quinazolones. The examples describe the preparation of (3-methoxy-2-pyridyl)-acetone, (3-ethoxy - 2 - pyridyl) - acetone, (3 - methoxy - 2-piperidyl) - acetone, (3 - ethoxy - 2 - piperidyl)-acetone. 2 - Lithomethyl - 3 - methoxy pyridine is prepared as in the first stage of the above process in solution, for example, in hexane.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112279805-A
priorityDate 1964-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419894380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426670173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18630995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431936228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14050395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154097525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154093473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431927413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 35.